Cancer SurvivorshipNCT07712133
Improving Radon Education and Awareness in Cancer Patients and Their Extended Community
A study testing Educational Presentation in people with Cancer Survivorship, run by University of Utah at 1 site in United States.
Trial summary
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer Survivorship
- What is being tested?
- Educational Presentation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2026to Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult age 18 or older
- Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes)
- Resident of Utah, Wyoming, Idaho, Montana, or Nevada
- Able to provide consent
Who cannot join
- Below age 18
- Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada
- Not able to provide consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112
Kathryn Weaver, 801-646-4458, kathryn.weaver@hci.utah.edu
Judy Ou, PhD
About this study
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. This is a pilot study to develop and evaluate the impact of a clinic-based intervention that educates cancer survivors and their caregivers/families about radon and radon testing. This study will enroll survivors, caregivers, and interested family members or friends in this intervention because they are important decision-makers with respect to the survivors' cancer care and well-being. This intervention would occur in clinics that treat lung cancer as well as clinics that treat cancers for which radon is being investigated as a contributor to their etiology (e.g. breast, skin melanoma, gastrointestinal).
- Conditions
- Cancer Survivorship
- Being tested
- Educational Presentation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational PresentationBehavioural
A study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants.
The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams).
| Study group | Role | What they receive |
|---|---|---|
| Radon Educational Session | Other | One short, educational intervention presentation will be given. The educational component is estimated to take 15-30 minutes, depending on how many questions people have. Receives: Behavioral: Educational Presentation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Radon Knowledge
To compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels. Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.
Measured: up to 1 day
Secondary outcomes (1)
Proportion of Participants that Test for Radon
To identify the proportion of participants that test for radon after the intervention according to demographics, estimated residential radon levels, and offered financial incentive.
Measured: up to 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2026
- Study startSep 2026 (estimated)
- Primary completionJun 2028 (estimated)
- Study completionJun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer SurvivorshipStudies of the same condition, open and under way.
- More trials run by University of UtahThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Collaborators
- Huntsman Cancer Institute
- Responsible party
- Sponsor
- Investigators
- Judy Ou, PhD, Principal investigator, Huntsman Cancer Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07712133
- Sponsor's protocol ID
- 192718
- Status last verified
- Jul 2026
- First submitted
- 7 Jul 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Radon Education and Awareness in Cancer Patients and Their Extended Community
- ClinicalTrials.gov ID
- NCT07712133
- Acronym / sponsor ID
- 192718
- Conditions
- Cancer Survivorship
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of UtahUniversity, hospital or other
- Collaborators
- Huntsman Cancer Institute
- Study start
- Sep 2026 (estimated)
- Primary completion
- Jun 2028 (estimated)
- Study completion
- Jun 2028 (estimated)
- First posted
- 17 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. This is a pilot study to develop and evaluate the impact of a clinic-based intervention that educates cancer survivors and their caregivers/families about radon and radon testing. This study will enroll survivors, caregivers, and interested family members or friends in this intervention because they are important decision-makers with respect to the survivors' cancer care and well-being. This intervention would occur in clinics that treat lung cancer as well as clinics that treat cancers for which radon is being investigated as a contributor to their etiology (e.g. breast, skin melanoma, gastrointestinal).
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Radon Educational Session | Other | Behavioral: Educational PresentationOne short, educational intervention presentation will be given. The educational component is estimated to take 15-30 minutes, depending on how many questions people have. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adult age 18 or older
- Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes)
- Resident of Utah, Wyoming, Idaho, Montana, or Nevada
- Able to provide consent
Key exclusion criteria (3 listed)
- Below age 18
- Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada
- Not able to provide consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational PresentationA study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants. The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams). | Behavioural | Radon Educational Session |
Primary outcome
Change in Radon Knowledge
Time frame: up to 1 day
To compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels. Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.
1 secondary outcome
Proportion of Participants that Test for Radon
Time frame: up to 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Cancer Survivorship
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Cancer, Survivorship
Not yet recruiting
Patient-reported Outcomes-driven Supportive Care Navigation Among Hispanic/Latinx Cancer Patients
Cancer
Not yet recruitingPhase 2
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission
RecruitingPhase 1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC)
Recruiting
Facial Expression Awareness Training to Understand and Recognize Emotions
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Judy Ou, PhD principal investigator
Huntsman Cancer Institute
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational Presentation in people with Cancer Survivorship, run by University of Utah at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kathryn Weaver (801-646-4458, kathryn.weaver@hci.utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Radon Knowledge (time frame: up to 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.